<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>AIMS/HYPOTHESIS: The aim of this meta-analysis is to determine the predictive value of diabetic <z:hpo ids='HP_0000488'>retinopathy</z:hpo> in differentiating diabetic <z:hpo ids='HP_0000112'>nephropathy</z:hpo> from non-<z:e sem="disease" ids="C0011881" disease_type="Disease or Syndrome" abbrv="">diabetic renal diseases</z:e> in patients with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> and <z:e sem="disease" ids="C0022658" disease_type="Disease or Syndrome" abbrv="">renal disease</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: Medline and Embase databases were searched from inception to February 2012 </plain></SENT>
<SENT sid="2" pm="."><plain>Renal biopsy studies of participants with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> were included if they contained data with measurements of diabetic <z:hpo ids='HP_0000488'>retinopathy</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>Pooled sensitivity, specificity, positive predictive value, negative predictive value and other diagnostic indices were evaluated using a random-effects model </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: The meta-analysis investigated 26 papers with 2012 patients </plain></SENT>
<SENT sid="5" pm="."><plain>The pooled sensitivity and specificity of diabetic <z:hpo ids='HP_0000488'>retinopathy</z:hpo> to predict diabetic <z:hpo ids='HP_0000112'>nephropathy</z:hpo> were 0.65 (95% CI 0.62, 0.68) and 0.75 (95% CI 0.73, 0.78), respectively </plain></SENT>
<SENT sid="6" pm="."><plain>The pooled positive and negative predictive value of diabetic <z:hpo ids='HP_0000488'>retinopathy</z:hpo> to predict diabetic <z:hpo ids='HP_0000112'>nephropathy</z:hpo> were 0.72 (95% CI 0.68, 0.75) and 0.69 (95% CI 0.67, 0.72), respectively </plain></SENT>
<SENT sid="7" pm="."><plain>The area under the summary receiver operating characteristic curve was 0.75, and the diagnostic odds ratio was 5.67 (95% CI 3.45, 9.34) </plain></SENT>
<SENT sid="8" pm="."><plain>For proliferative diabetic <z:hpo ids='HP_0000488'>retinopathy</z:hpo>, the pooled sensitivity was 0.25 (95% CI 0.16, 0.35), while the specificity was 0.98 (95% CI 0.92, 1.00) </plain></SENT>
<SENT sid="9" pm="."><plain>There was <z:hpo ids='HP_0001425'>heterogeneity</z:hpo> among studies (p &lt; 0.001), and no publishing bias was identified </plain></SENT>
<SENT sid="10" pm="."><plain>CONCLUSIONS/INTERPRETATION: Diabetic <z:hpo ids='HP_0000488'>retinopathy</z:hpo> is useful in diagnosing or screening for diabetic <z:hpo ids='HP_0000112'>nephropathy</z:hpo> in patients with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> and <z:e sem="disease" ids="C0022658" disease_type="Disease or Syndrome" abbrv="">renal disease</z:e> </plain></SENT>
<SENT sid="11" pm="."><plain>Proliferative diabetic <z:hpo ids='HP_0000488'>retinopathy</z:hpo> may be a highly specific indicator for diabetic <z:hpo ids='HP_0000112'>nephropathy</z:hpo> </plain></SENT>
</text></document>